Interestingly, in Npc1−/− mice, treatment with bimoclomol prevented cerebellar atrophy and preserved cerebellar weights at wild-type weights (p = 0.025; two-way ANOVA), whereas this improvement was blocked by co-administration with saracatinib (Fig. 5c). This evidence concerns the gene NPC1 and Cerebellar atrophy.